EQRx, Inc.

EDGAR

Market value is not computed: no recent price is available.

28 filing records in this dataset, filed from 2021-02-25 to 2023-11-06. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

See all insider transactions

Cash and cash equivalents
316 million USD Source
Exact value

315676000 USD

Long-term debt including current maturities
Not available
Shares outstanding
485 million shares Source
Exact value

484965759 shares

Reported share-count change

1.78% · 8.47 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 476499567 shares · 2022-09-30· Source
  • 484965759 shares · 2023-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-260 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence
  • Net income: -169089000 USD · 2022-01-01 – 2022-12-31 Source
  • Net income: -146912000 USD · 2022-01-01 – 2022-09-30 Source
  • Net income: -82551000 USD · 2023-01-01 – 2023-03-31 Source
  • Net income: -72956000 USD · 2023-04-01 – 2023-06-30 Source
  • Net income: -82631000 USD · 2023-07-01 – 2023-09-30 Source

Operating cash flow

-330 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence
  • Operating cash flow: -287268000 USD · 2022-01-01 – 2022-12-31 Source
  • Operating cash flow: -181472000 USD · 2022-01-01 – 2022-09-30 Source
  • Operating cash flow: -85546000 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -162437000 USD · 2023-01-01 – 2023-06-30 Source
  • Operating cash flow: -85546000 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -224344000 USD · 2023-01-01 – 2023-09-30 Source
  • Operating cash flow: -162437000 USD · 2023-01-01 – 2023-06-30 Source

Capital expenditure

1.55 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence
  • Capital expenditure: 1133000 USD · 2022-01-01 – 2022-12-31 Source
  • Capital expenditure: 176000 USD · 2022-01-01 – 2022-09-30 Source
  • Capital expenditure: 444000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 594000 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 444000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 594000 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 594000 USD · 2023-01-01 – 2023-06-30 Source

Free cash flow

-332 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence
  • Operating cash flow: -287268000 USD · 2022-01-01 – 2022-12-31 Source
  • Operating cash flow: -181472000 USD · 2022-01-01 – 2022-09-30 Source
  • Operating cash flow: -85546000 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -162437000 USD · 2023-01-01 – 2023-06-30 Source
  • Operating cash flow: -85546000 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -224344000 USD · 2023-01-01 – 2023-09-30 Source
  • Operating cash flow: -162437000 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 1133000 USD · 2022-01-01 – 2022-12-31 Source
  • Capital expenditure: 176000 USD · 2022-01-01 – 2022-09-30 Source
  • Capital expenditure: 444000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 594000 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 444000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 594000 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 594000 USD · 2023-01-01 – 2023-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-11-06.

Financial data available through: 2022-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 3 of 11 periods available· newest 2022-12-31
  • Net income: 3 of 11 periods available· newest 2022-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2022-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2022-12-31
  • Total assets: 3 of 11 periods available· newest 2022-12-31
  • Total liabilities: 3 of 11 periods available· newest 2022-12-31
  • Current assets: 3 of 11 periods available· newest 2022-12-31
  • Current liabilities: 3 of 11 periods available· newest 2022-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2022-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 3 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −USD 69.08 million

    Prior period

    −USD 100.01 million

    –

    Current period

    −USD 169.09 million

    –

    Exact inputs and evidence

    -169089000 − -100009000 = -69080000 USD

    -100009000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -169089000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 104.09 million

    Prior period

    −USD 183.18 million

    –

    Current period

    −USD 287.27 million

    –

    Exact inputs and evidence

    -287268000 − -183180000 = -104088000 USD

    -183180000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -287268000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +152.9%

    Prior period

    USD 448,000

    –

    Current period

    USD 1.13 million

    –

    Exact inputs and evidence

    1133000 − 448000 = 685000 USD

    448000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    1133000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2020 2020-01-01 – 2020-12-31
−USD 250 million
Exact value

Exact value: -250000000 USD

2020-01-01 – 2020-12-31: -250000000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 241.51 million
Exact value

Exact value: -241506000 USD

2020-01-01 – 2020-12-31: -241506000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.98 million
Exact value

Exact value: 2980000 USD

2020-01-01 – 2020-12-31: 2980000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 244.49 million
Calculation and evidence

-241506000 − 2980000 USD

Exact free cash flow: -244486000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 100.01 million
Exact value

Exact value: -100009000 USD

2021-01-01 – 2021-12-31: -100009000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 183.18 million
Exact value

Exact value: -183180000 USD

2021-01-01 – 2021-12-31: -183180000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 448,000
Exact value

Exact value: 448000 USD

2021-01-01 – 2021-12-31: 448000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 183.63 million
Calculation and evidence

-183180000 − 448000 USD

Exact free cash flow: -183628000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 169.09 million
Exact value

Exact value: -169089000 USD

2022-01-01 – 2022-12-31: -169089000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 287.27 million
Exact value

Exact value: -287268000 USD

2022-01-01 – 2022-12-31: -287268000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.13 million
Exact value

Exact value: 1133000 USD

2022-01-01 – 2022-12-31: 1133000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 288.4 million
Calculation and evidence

-287268000 − 1133000 USD

Exact free cash flow: -288401000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

28 filings · 749 latest values · 749 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001843762, 1843762, CMLT, edgar:1843762

Also known as CM LIFE SCIENCES III INC., CM Life Sciences III Inc., EQRx, Inc.